Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04688372 · ClinicalTrials.gov registry record

Hospital COVID-19 Surge and Associated Mortality Risk

A clinical trial, sponsored by National Institutes of Health Clinical Center (CC).

Completed
Registry status
144,116
Enrollment target

NCT04688372 is a clinical trial that has completed, run by National Institutes of Health Clinical Center (CC). The registered enrollment target is 144,116 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04688372 has completed, sponsored by National Institutes of Health Clinical Center (CC).

COMPLETED
Registry status
144,116 participants
Enrollment target

Study Summary

A retrospective cohort study will be conducted using a large administrative database of U.S. hospitals to understand the volume-outcome relationship among patients hospitalized with COVID-19.

Interventions

  • OTHER Surge Index

Trial Details

FieldValue
Enrollment Target 144,116 participants
Start Date 2020-10-01
Est. Completion 2021-02-15

What the Registry Record Tells You About NCT04688372

The ClinicalTrials.gov registry entry for NCT04688372 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 144,116 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institutes of Health Clinical Center (CC), which has 338 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Surge Index is the first listed.

NCT04688372 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04688372 about?

NCT04688372 is a clinical study titled "Hospital COVID-19 Surge and Associated Mortality Risk". A retrospective cohort study will be conducted using a large administrative database of U.S. hospitals to understand the volume-outcome relationship among patients hospitalized with COVID-19.

What is the current status of trial NCT04688372?

This trial is currently completed. The enrollment target is 144,116 participants. The study started on 2020-10-01. Estimated completion is 2021-02-15.

What interventions are being tested in trial NCT04688372?

The interventions under investigation include: Surge Index (OTHER).

Who is sponsoring clinical trial NCT04688372?

This trial is sponsored by National Institutes of Health Clinical Center (CC), which has 338 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.